f-13640 and Diabetes-Mellitus--Type-1

f-13640 has been researched along with Diabetes-Mellitus--Type-1* in 1 studies

Other Studies

1 other study(ies) available for f-13640 and Diabetes-Mellitus--Type-1

ArticleYear
Improvement of urethral dysfunction by 5-HT
    Neurourology and urodynamics, 2022, Volume: 41, Issue:7

    To examine the effects of the selective 5-HT. Female Sprague-Dawley rats (n = 32) were divided into two groups: rats with type 1 diabetes mellitus (T1DM) and age-matched normal control rats (NC). T1DM was induced by intraperitoneal injection of streptozotocin (65 mg/kg). Isovolumetric cystometry and urethral perfusion pressure (UPP) were evaluated 10 weeks postinjection in rats (n = 9 per group). The selective 5-HT. Compared to controls, type 1 diabetic rats (T1D rats) had lower maximal intravesical pressure (IP max) and UPP changes. In T1D rats, NLX-112 hydrochloride (0.003-1.0 mg/kg) induced dose-dependent decreases in UPP nadir, IP max, high-frequency oscillations (HFOs) rate; and increases in UPP change and HFOs amplitude. WAY-100635 maleate salt (0.3 mg/kg) partially or completely reversed the NLX-112-induced changes. Immunofluorescence revealed that 5-HT. Urethral dysfunction in T1D rats was improved by NLX-112. 5-HT

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Maleates; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Streptozocin; Urethra

2022